Do you have a link to the cdc discrediting the pcr?
THOSE FUCKERS EDITED THE PAGE!!! The original clearly said the PCR test , regardless of amplification rounds, COULD NOT DISCERN BETWEEN Influenza-A Influenza-B or SARS-2!!! It still gets to the point though. The original ALSO said they had no isolated genetic sample when they designed the original test still in use!!!! In fact The announcement of first isolate was mid dec 2020. mid-fucking-December 2020.
Now it just says PCR test must be multiple tests :
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses
Translation: They’ve been adding flu cases to COVID cases when using that test!
also , though there is a SARS-2 virus, the human samples are 99% of the time just influenza not SARS-2 :
No Trace of This Virus at All. Found Only Type A and B Influenza Viruses: https://canadianmale.wordpress.com/2021/06/04/the-virus-is-fictitious-cdc-sued-by-7-universities-scientists-for-huge-fraud/
Discredited and has been pulled, a new “gold standard” test will be released December 31st.
Oh, no link.
The search bar above “pcr”. It’s been talked about for weeks here. The cdcd quietly announced it.
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
Full article why it was pulled, will the new test be more accurate, who knows.
(post is archived)